Thyroid cancer is a common endocrine malignancy. There has been exciting progress in
understanding its molecular pathogenesis in recent years, as best exemplified by the …

Thyroid cancer is the most common endocrine malignancy. With a rapidly rising incidence in
recent years, novel efficient management strategies are increasingly needed for this cancer …

Thyroid cancer is the most common endocrine malignancy giving rise to one of the most
indolent solid cancers, but also one of the most lethal. In recent years, systematic studies of …

There is now a reasonably good understanding of the key oncogenic events involved in the
initiation and progression of thyroid cancer. Many of these are characteristic of certain tumor …

Biologic and Clinical Perspectives on Thyroid Cancer | NEJM Skip to main content NEJM
Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a …

Thyroid cancer comprises different clinical and histological entities. Whereas differentiated
(DTCs) malignancies are sensitive to radioiodine therapy, anaplastic (ATCs) and medullary …

Thyroid carcinoma consists a group of phenotypically heterogeneous cancers. Recent
advances in biological technologies have been advancing the delineation of genetic …

Differentiated thyroid cancer (DTC) is the most common endocrinological malignancy. There
are several histological variants such as papillary and follicular thyroid carcinoma. Many …

A wealth of knowledge regarding the molecular causation of thyroid carcinoma has been
accumulated over the past five years. This information has already had a significant impact …

There are 5 main histological types of thyroid cancers (TCs): papillary, follicular (also known
as differentiated), poorly differentiated, anaplastic (the most aggressive form), and medullary …